Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Marks Milestone as First Hemp Company to Develop ESG Report Using SASB Framework

Green Hygienics (OTCQB: GRYN), an innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, has announced the publication of its first annual Environmental, Social and Governance (“ESG”) Report. The company published the report using the Sustainability Accounting Standards Board (“SASB”) framework and, according to the announcement, is the first industrial hemp company in the United States to do so. GRYN’s inaugural report validates the company’s commitment to establishing a benchmark in the industry and its focus in creating a more sustainable future in three distinct areas: economic viability, eco-responsibility and social equity. The company is collaborating with Keramida Inc., a premier environmental engineering and sustainability consulting firm, as it works to fulfill its states mission of enhancing long-term company value while promoting a more transparent path of sustainable development. In addition, Green Hygienics is working to reduce the impact of climate change, and this summer, the company became a proud member of the 1% for the Planet program, a group whose members donate 1% of future profits to nonprofit organizations that are working to resolve the planet’s most pressing environmental issues. “Our financial and operational performance and key strategic objectives are dependent on our relationships and understanding our environmental impact,” said Green Hygienics CEO Ron Loudoun in the press release. “Our ESG report will set key performance indicators and provide coherent information useful to our stakeholders.”

To view the full press release, visit https://cnw.fm/mAZwi

About Green Hygienics Holdings Inc.

Green Hygienics is focused on the hygienics, or science, of preserving and promoting the health of individuals, communities and the planet; this is the company’s core mission and is at the heart of every decision the company makes. As more and more consumers prioritize their health and demand transparency and integrity from the companies that create their products, Green Hygienics will be recognized as the most reliable, safe and secure choice in the market for CBD and hemp products. To deliver on this promise, the company maintains a constant commitment to sustainable farming practices, cutting-edge science and industry-leading certifiability. Generating peak value from a plant of this caliber requires prioritizing innovative processing methods and impeccable attention to detail. Creating a secure supply chain and reliable long-term source for high-grade CBD is a corporate strategy for Green Hygienics, coupled with a mission to preserve and protect a valuable natural resource. As Green Hygienics evolves and expands, its path is clear and uncompromised, creating pure, nonpsychoactive nutraceutical, pharmaceutical, topical and industrial products from the highly sustainable hemp plant to benefit people and preserve the planet. For more information about the company, visit www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — The Potential Benefits of CBD Skincare Products

You have probably heard of CBD, or cannabidiol, before. Extracted from cannabis or hemp, this chemical compound is said to have a wide variety of medical applications ranging from relieving pain and anxiety to treating seizures in epileptic patients. Thanks to its supposed medical potential, CBD can now be found in myriad wellness and health products, with the skincare industry especially taking a liking to the versatile hemp extract. But just how beneficial are these CBD-infused sunscreens, lip balms, moisturizers, lotions, masks and other skincare offerings?

According to Austin Kaz, a co-founder of New York-based Sheabrand, skincare product manufacturers add CBD to their products to give those products an extra kick, making them much more effective at treating skin conditions, including acne, eczema and dry skin. One of cannabidiol’s more well-known uses is as an anti-inflammatory agent, making it a great addition to products meant to address inflammatory skin conditions such as eczema, psoriasis and dermatitis. CBD does this by interacting with the receptors in the endocannabinoid system and reducing interleukins, which are cell-signaling molecules that can stimulate inflammation.

A couple of studies have found that CBD may have the ability to nourish and rejuvenate dry skin, subsequently reducing itching. Results from a study published in the March–April issue of  “Journal Clinical Therapeutics” show that CBD may be able to improve levels of skin hydration by moisturizing the skin and preventing it from losing water and boost skin elasticity. However, the researchers behind the study say this may be due to CBD’s anti-inflammatory properties or the fatty acids in the ointments the participants used, so more research with a much larger set of participants is needed.

Usually, dermatologists will prescribe topical steroidal creams, which act as anti-inflammatory agents, to treat some skin diseases. While these creams are perfectly safe and work great for most people, some individuals are not comfortable with using steroids of any kind. Robert Dellavalle, an adjunct professor of epidemiology at the Colorado School of Public Health, says that nonsteroidal therapies that use CBD can fill this gap. This type of therapy has also achieved promising results against a condition that affects millions of people from puberty well into adulthood: acne.

CBD’s anti-inflammatory properties combined with its influence on the production of sebum by skin cells via the CB2 receptors on the sebaceous glands make cannabinoid a potential therapy against acne. Additionally, research shows that topical CBD may be able to help kill gram-positive bacteria that are a known cause of acne. Finally, a CBD-infused sunscreen may help alleviate the effects of sunburns, such as redness.

However, do not look at CBD as a cure-all. Most of the evidence in its favor is anecdotal, and researchers say that even though preliminary studies have uncovered positive results, more research is needed. For the time being, do your homework on CBD, choose high-quality products and make sure you speak to your doctor before you use CBD, especially if you are pregnant or on other medication.

Companies such as Hero Technologies Inc. (OTC: HENC) focus on offering the benefits of CBD while making infused products addressing the skincare needs of their clients.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — CBD Cosmetics Market Expected to Expand to $210 Billion by 2028

A recently published report that focused on the burgeoning CBD market estimates that by 2028, the global legal cannabis market will have reached $70.6 billion. Marijuana is one of the largest growth industries on the stock market. However, not all cannabis business segments are equal, with estimates showing that in the near future, some segments will considerably surpass others. One specific segment to watch is the CBD-infused products market.

CBD, or cannabidiol, is the nonpsychoactive compound found in the hemp and cannabis plants. It is one of the two most abundant compounds found in the cannabis plant, with the other compound being THC, which is psychoactive.

Currently, the edibles segment makes up the biggest share of the CBD-infused market. However, the cosmetics segment is expected to occupy a larger share in the near future. CBD-infused products include salves, lotions, gels and balms, which can be applied directly to the skin. These topicals are used for various symptoms, including muscle soreness, inflammation and localized pain.

You may be asking yourself if CBD-infused personal care products can really do all that.

In fact, studies have shown that CBD possesses anti-oxidant and anti-inflammatory properties, which may help deal with skin issues such as acne. Research has also found that CBD-infused topicals can be used to treat other issues, including psoriasis, dermatitis, cramping, headaches and arthritis.

Many individuals want to feel and look younger and healthy. This is why the international personal care and beauty market is valued at roughly $420 billion, with projections showing that by 2026, the market will have hit almost $560 billion. The increased adoption of these personal- care products is a main facilitator of the global CBD market’s growth. The market is expected to expand at a compound annual growth rate of 26.5%.

Forecasts show that between now and 2028, the CBD-infused product market will reach $216.7 billion, expanding at a compound annual growth rate of 45.6%. Projections also show that in the period between 2020 and 2024, the cosmetics market will expand at a compound annual growth rate of about 25%.

Canada and the United States are leading this growth, with at least 35 states in the U.S. legalizing medical cannabis, and Canada legalizing both recreational and medical marijuana. Other key markets for CBD-infused cosmetics include the United Kingdom, Mexico, China and Germany.

Various companies have joined the CBD-infused cosmetics market, including Valens Company Inc., which is involved in the sale of health as well as wellness products such as CBD bath bombs. Flora Growth Corp. (NASDAQ: FLGC) has also entered the market and offers a line of CBD wellness products.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Slated for Live Webcast at VirtualInvestorConferences.com

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“CBN”), will be featured at the upcoming VirtualInvestorConferences.com. InMed president and CEO is scheduled to present a real-time, interactive presentations during the two-day conference; InMed’s presentation will start at 1:30 p.m. ET on Sept. 8, 2021. During the presentation Adams will provide an overview of the company’s recent highlights as well as answer questions from potential investors in real time. Company highlights include the announcement that it has increased the yield of its proprietary IntegraSyn(TM) rare cannabinoid manufacturing approach to 5 g/L, further improving the overall economics in advance of commercial-scale production and that it has signed a nonbinding letter of intent to acquire BayMedica, a private company that specializes in the manufacture and commercialization of rare cannabinoids. In addition, as part of a phase 2 clinical trial, InMed has filed clinical trial applications in several countries. Virtual Investor Conferences (“VIC”) has developed a reputation for being a leading proprietary investor conference series; VIC events provide an interactive forum for publicly traded companies to meet and present directly with investors.

To register for the event, visit https://cnw.fm/g2Lii

To view the full press release, visit https://cnw.fm/T0KhW

About InMed Pharmaceuticals Inc.

InMed is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”) and is developing IntegraSyn to produce pharmaceutical-grade cannabinoids. The company is dedicated to delivering new therapeutic alternatives to patients who may benefit from cannabinoid-based pharmaceutical drugs. For more information, please visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Trials on Marijuana-Based Treatments for Gynecological Conditions to Begin in 2022

Clinical trials to examine the effectiveness and safety of marijuana-based treatments for various gynecological conditions are expected to begin early next year. The trials will evaluate marijuana-based pharmacology products developed by Gynica, a female technology startup company based in Jerusalem.

The startup believes that the plant’s active ingredients can help ease painful gynecological conditions, including endometriosis and painful menstruation, which is also known as dysmenorrhea. Traditional treatments, such as hormone therapy, over-the-counter painkillers and surgical intervention. can be inadequate and pose their own health risks, as in the case of endometriosis.

Endometriosis is a disorder which causes tissues that normally line the uterus, known as the endometrium, to grow outside the uterus. These tissues usually become trapped inside the body and thicken, causing a build-up of adhesions and scar tissue. This results in excessive bleeding, painful intercourse and painful menstruation. In some cases, endometriosis can cause infertility.

Endometriosis has no definitive cause and no cure. It takes between 6 to 10 years for the disorder to be properly diagnosed, despite the fact that it affects every 1 in 10 women of reproductive age globally. This equates to about 180 million girls and women around the globe.

Gynica hopes to meet these unaddressed needs in women’s health by developing marijuana-based solutions for these gynecological conditions.

The CEO and co-founder of the start-up, Yotam Hod, stated that there exists so many gaps in how conditions that affect women are handled by both the scientific community and the medical community. The company has developed proprietary vaginal suppositories, which Hod says have been designed to decrease pain as well as inflammation, which is a key factor in both dysmenorrhea and endometriosis.

Dysmenorrhea is also common, with physicians noting that the associated pain varies between mild and severe. It is estimated that between 40% and 95% of women of reproductive age suffer from dysmenorrhea. Physicians note that for some individuals, dysmenorrhea and endometriosis are related.

Gynica believes that endometriosis and dysmenorrhea may be associated with a deficiency in the endocannabinoid system. The company references published research, which states that, after the brain, the female reproductive system is the region with the most endocannabinoid receptors. The endocannabinoid system is comprised of natural marijuana-like molecules produced by the human body, which regulate processes such as reproductive function, sleep, mood, appetite and pain.

Hod notes that their solutions show promise for treating these conditions and maintains that cannabinoid-based treatments may provide an improved solution for women who suffer from these conditions.

If successful, these trials could lend further credence to the profile of marijuana as a medicinal plant. The entire cannabis sector, including companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), could benefit from the positive news such outcomes would trigger.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Low-Potency Cannabis Drinks Look to Dominate Beverages Market

The past few years have seen the cannabis industry grow from essentially nothing to a juggernaut worth billions of dollars in sales. Cannabis edibles have reigned supreme, with CBD gummies being among the most searched for foods online in 2018 thanks, in part, to their discreetness and ease of use. One of the fastest-growing industries in America, the state-legal cannabis sector is constantly in flux, and players in this controversial space are now looking to cash in on a new product that has been gaining more mainstream attention: cannabis beverages.

Forget alcohol or your daily cup of coffee — customers have been increasingly looking for alternatives to common beverages and low-potency, cannabis-infused drinks have emerged as a strong contender. Thanks to improving technology, companies in the cannabis space can now produce smooth and consistently dosed cannabis drinks, making them a viable option for customers who would like to kick back with a nice, relaxing drink that won’t leave them grappling with a hangover the next day.

According to a 2021 report by cannabis analytics firm Headset, cannabis beverage sales have remained at around 1% for the past five years. However, thanks to advancements in cannabis-infusion technology and the entry of several new brands, the cannabis drinks segment has plenty of growth potential.

Headset says that cannabis drinks sales in Canada have risen to nearly 4.5% of total cannabis sales since the start of 2020 while leading industry analyst Million Insights says the global cannabis beverages will be worth $2.8 billion by 2025, growing at a compound annual growth rate (CAGR) of 17.8%. Despite being a relatively young segment, the cannabis beverage space has seen an influx of SME craft companies and larger companies looking to cash in on the increasingly popular product. Heineken, for instance, recently launched a line of cannabis-infused, zero-carb and zero-calorie drinks under the Hi-Fi Hops brand. In addition, Canopy Growth partnered with Constellation brands while HEXO partnered with Moors Coors to create Truss Beverages.

People are looking for cleaner, safer ways to consume cannabis, especially in the wake of the coronavirus pandemic, which showed just how detrimental smoking can be and sparked a growing trend toward healthier, less-sugary drinks. A growing number of cafes, lounges and restaurants are already anticipating demand for cannabis beverages, with a 2020 survey of retail sales data in Canada revealing that cannabis-infused drinks had greater growth rates compared to edibles.

Furthermore, another 2020 study conducted for Truss found that awareness of cannabis beverages was at an all-time high at 87% and that 35% of the respondents already consumed cannabis drinks as an alternative to smoking. Only time will tell how the cannabis-infused segment fares. With cannabis beverages sector players such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) consolidating their position in this segment, consumers have a lot to look forward to.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugar Announces the Launch of CRÈME – Premium Hemp Cigarette

Sugar is setting itself apart from its competitors in the burgeoning industry of hemp cigarettes, promising the highest-quality lab-tested ingredients, a potent dose of CBD and the smoothest experience on the market. Now, with its proprietary hemp blend, the company has announced the launch of CRÈME by Sugar cigarettes with two signature flavors: Original and Peppermint. Original allows smokers to savor Sugar’s premium hemp blend in its natural state — enhanced with Sugar’s signature Sweet Tip filter. Peppermint combines Sugar’s premium hemp and the company’s proprietary flavoring technique with organic peppermint leaf— delivering a delectable, mint-chocolate taste. Both varieties boast more than 1,000 mg of CBD in every pack, with additional flavor profiles coming soon. “Our goal was to create a product that we could be passionate about,” said William Hsu, Sugar’s managing partner. “We didn’t want to rush the process. In the end, we succeeded in making a better tasting, smoother and higher-quality cigarette than our competitors.”

To view the full press release, visit https://cnw.fm/Uf1rx

About Sugar

“Our vision is to bring more flavor to the world.”

Based out of Los Angeles, California, Sugar is an industry leader and maker of fine hemp cigarettes. In everything that it does, Sugar prioritizes excellence. The company’s mission is to create the best flavored hemp products using only the highest quality ingredients. In addition to beautiful design, Sugar also creates beautiful experiences. For more information or wholesale inquiries, please visit www.SugarCali.com or email biz@sugarcali.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Clear Path to Execute Business Strategy in Michigan

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced its receipt of adult use (recreational use) prequalification status pursuant to the licensing provisions of the Michigan Regulation and Taxation of Marihuana Act (“MRTMA”) and associated rules through a wholly owned operating subsidiary, RWB Michigan, LLC. According to the update, this Marijuana Regulatory Agency (“MRA”) approval represents the company’s authorization to move forward with its full operational strategy in the state of Michigan and complete the licensing process for its intended facilities. “Michigan has been one of the highest bars of entry to any market we’ve entered,” said RWB CEO and Chairman Brad Rogers. “The regulatory body has done it right, and all stakeholders should feel comfort with the level of scrutiny and governance they require to be compliant operators. This now provides a clear path for us to fully execute on our strategy of being the house of brands and being great channel partners to all of our distribution points as well as our own planned flagship retail locations.”

To view the full press release, visit https://cnw.fm/Sqj21

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Marks Milestone with Receipt of 2021 Commercial Export Quota of Psychoactive Cannabis Flower from Colombian Government

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has received its 2021 export quota from the Colombian Technical Quotas Group (“TQG”) of 7,900 kilograms of high-THC cannabis dried flower; the company anticipates using the dried flower for direct sale or to process into derivative products that will be exported. FLGC has already signed numerous agreements for the sale and distribution of the dried flower as well as derivative products into several international jurisdictions, including South Africa, Australia, Latin America and the European Union. FLGC management stated that receiving the quota was a milestone for the company and noted that the new 2021 export quota allocation should be sufficient for the company to meet the international demand for its products for the remainder of 2021 and into 2022. According to the company, the highest prices in the industry are in the psychoactive cannabis market, with the average wholesale price of THC distillate oil projected to reach anywhere from $3,500 to $8,000 per kilogram. “We have been eagerly anticipating and preparing for this announcement by cloning thousands of plants, which we currently have in propagation waiting to be transferred into our fields,” said Flora Growth vice president of agriculture Javier Franco in the press release. “While awaiting this quota, we were focused on optimizing our cultivation strategy and demonstrating our industry-leading production costs of just $0.06 per gram, while continuing to build out our facilities and applying for third party certifications. While we prioritize planting the new high-THC cultivars, it’s also important to note we are actively harvesting our high-CBD crops, and anticipate that this harvest will create a robust pipeline of cannabis derivatives for Flora to use across its premium brands and products, as well as for export to multiple international markets.”

To view the full press release, visit https://cnw.fm/H9qjr

About Flora Growth Corp.

Flora Growth is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Results of Human Clinical Study Showing Effective, Safe BP Reduction

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced that its human clinical study HYPER-H21-2, which features LEXX’s patented DehydraTECH(TM)-processed cannabidiol (“CBD”), demonstrates up to a 23% decrease in blood pressure when compared to placebo. According to the announcement, partial results are being released today with additional blood pressure subset analyses, sleep quality and all other data analyses will be reported when complete. Partial results indicate that at selected times during the 24-hour study, volunteers with mild to moderate hypertension averaged as much as a 20 mmHg (i.e., 23%) decrease in BP relative to placebo, with volunteers averaging a notable reduction of 7.0% (p<0.001) in systolic pressure. In addition, over the same period, volunteers averaged a significant reduction of 5.3% (p<0.001) in MAP and a significant reduction of 3.5% in diastolic pressure relative to an increase in diastolic pressure (-0.8 vs. +2.7; p<0.001) from baseline with DehydraTECH-CBD relative to placebo treatment. The company noted that these numbers are particularly remarkable because many drugs currently used to treat hypertension require several weeks of treatment and/or combination dosing before they produce comparable results. Moving forward, Lexaria will evaluate the results of its first two human clinical hypertension studies before its upcoming pulmonary human clinical hypertension study of 2021 begins. “Over the initial 24 hours, Lexaria’s 2021 hypertension program is now delivering blood pressure reduction results competitive with — and in some cases even superior to — established oral pharmaceutical hypertension drugs,” said Lexaria CEO Chris Bunka in the press release. “DehydraTECH-CBD demonstrated a sustained and augmented effect upon blood pressure attenuation throughout the day, indicating effectiveness of the repeat dosing treatment schedule used in this study.”

To view the full press release, visit https://cnw.fm/OGIp9

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption of cannabinoids and nicotine by 5 to 10 times, and, in some instances with cannabinoids by as much as 27 times, compared to standard industry formulations, as well as reduce time of onset from one to two hours to minutes, and mask unwanted tastes. The delivery systems are also being evaluated for orally administered, anti-viral drugs, nonsteroidal, anti-inflammatory drugs (NSAIDs) and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted and more than 50 patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.